Condition

Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions6

Lead sponsors shown2

Clinical trials

2 shown

A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) PatientsNCT06879717 · 2025-04-22

ACTIVE_NOT_RECRUITING

Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 InhibitorNCT03041181 · 2017-01-27

TERMINATED

Common interventions

DocetaxelDRUG2DostarlimabDRUG1GemcitabineDRUG1NivolumabDRUG1PemetrexedDRUG1roginolisibDRUG1

Leading sponsors

iOnctura1Nasser Hanna, M.D.1

Trial status mix

ACTIVE_NOT_RECRUITING1

TERMINATED1

Phase mix

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.